Louisville-based company receives FDA approval for injectable overdose-reversal device

Updated: Sep. 26, 2022 at 11:00 PM EDT
Email This Link
Share on Pinterest
Share on LinkedIn
ZimHi is the first ever FDA-approved injectable Naloxone device that can reverse the deadly effects of an overdose.